ABSTRACT
Rapid population aging elevates burden of chronic and non-communicable diseases among older adults. Despite the critical role of self-management in disease prevention and control, effective management of diseases can be cognitively demanding and may require additional supports from family, friends and social services. Using nationally representative data from China, this paper documents the gradient relationship between cognitive impairment and disease management, and characterizes the differential effects of long-term care services and supports (LTSS) on disease management among older adults in different stages of cognitive impairment. In specific, we examine preventive care use and the management of hypertension, a highly prevalent but inadequately addressed chronic disease in China. We find that a severer stage of cognitive impairment is associated with poorer performance in disease prevention, hypertension awareness and management. While some of the LTSS offered by spouse, friends or community significantly facilitate active disease management behaviors, the effects are only evident among older adults with no cognitive impairment. By contrast, we find no significant effect of LTSS among cognitively impaired individuals. These findings reveal the vulnerability of older adults with cognitive impairment in disease management, and point to the importance of promoting targeted interventions to reduce barriers of receiving and utilizing LTSS, especially among cognitively impaired population.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Financial supports from Yale Macmillan Center faculty research award, the U.S. PEPPER Center Scholar Award (P30AG021342), and a NIH/NIA grant (K01AG053408) are acknowledged. The current study was conducted at the Yale School of Public Health. The funders had no role in the study design; data collection, analysis, or interpretation; in the writing of the report; or in the decision to submit the article for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This research uses China Health and Retirement Longitudinal Study (CHARLS), a publicly available social survey with completely de-identified information. The CHARLS was approved by the Biomedical Ethics Review Committee of Peking University. All persons provided informed consent.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
E-mail address: zhuoer.lin{at}yale.edu (Z.L), xi.chen{at}yale.edu (X.C)
Data Availability
Data are obtained from China Health and Retirement Longitudinal Study (CHARLS), a nationally representative survey of Chinese older adults age 45 years or older. The national baseline was conducted in 2011, and the respondents were longitudinally followed up in 2013, 2015, and 2018. All waves are publicly available upon submitting a form of data user agreement.
